NASDAQ:DSCI - Derma Sciences Stock Price, Forecast & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Derma Sciences Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume719,592 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Derma Sciences, Inc (Derma Sciences) is a medical device company. The Company operates through two segments: advanced wound care and traditional wound care products. Advanced wound care products principally consist of both novel and otherwise differentiated dressings, devices and skin substitutes designed to promote wound healing and/or prevent infection. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryHealth Care Supplies SectorN/A Current SymbolNASDAQ:DSCI Previous Symbol CUSIP24982750 CIK892160 Webhttp://www.dermasciences.com/ Phone+1-609-5144744Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive DSCI News and Ratings via Email Sign-up to receive the latest news and ratings for DSCI and its competitors with MarketBeat's FREE daily newsletter. Derma Sciences (NASDAQ:DSCI) Frequently Asked Questions What is Derma Sciences' stock symbol? Derma Sciences trades on the NASDAQ under the ticker symbol "DSCI." How were Derma Sciences' earnings last quarter? Derma Sciences Inc (NASDAQ:DSCI) posted its quarterly earnings data on Tuesday, August, 9th. The medical instruments supplier reported $0.08 earnings per share for the quarter, beating analysts' consensus estimates of ($0.08) by $0.16. The medical instruments supplier earned $22.20 million during the quarter, compared to analysts' expectations of $22.40 million. View Derma Sciences' Earnings History. Has Derma Sciences been receiving favorable news coverage? Media stories about DSCI stock have trended negative this week, InfoTrie reports. The research group identifies positive and negative news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Derma Sciences earned a media sentiment score of -2.0 on InfoTrie's scale. They also assigned media coverage about the medical instruments supplier a news buzz of 2.0 out of 10, meaning that recent news coverage is very unlikely to have an impact on the company's share price in the next several days. View News Stories for Derma Sciences. Who are some of Derma Sciences' key competitors? Some companies that are related to Derma Sciences include Align Technology (ALGN), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), West Pharmaceutical Services (WST), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), Quidel (QDEL), Merit Medical Systems (MMSI), STAAR Surgical (STAA), Atrion (ATRI), Cerus (CERS), Anika Therapeutics (ANIK), Antares Pharma (ATRS) and OraSure Technologies (OSUR). What other stocks do shareholders of Derma Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Derma Sciences investors own include NovaBay Pharmaceuticals (NBY), Novavax (NVAX), Progenics Pharmaceuticals (PGNX), Allena Pharmaceuticals (ALNA), Antares Pharma (ATRS), Fate Therapeutics (FATE), Genocea Biosciences (GNCA), Idera Pharmaceuticals (IDRA), Molecular Templates (MTEM) and Zogenix (ZGNX). What is Derma Sciences' official website? The official website for Derma Sciences is http://www.dermasciences.com/. How can I contact Derma Sciences? Derma Sciences' mailing address is 214 Carnegie Ctr Ste 300, PRINCETON, NJ 08540-6237, United States. The medical instruments supplier can be reached via phone at +1-609-5144744. MarketBeat Community Rating for Derma Sciences (NASDAQ DSCI)Community Ranking: 2.9 out of 5 ( )Outperform Votes: 235 (Vote Outperform)Underperform Votes: 168 (Vote Underperform)Total Votes: 403MarketBeat's community ratings are surveys of what our community members think about Derma Sciences and other stocks. Vote "Outperform" if you believe DSCI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DSCI will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/22/2020 by MarketBeat.com StaffFeatured Article: What is a recession?
